RESUMEN
Although there is a strong correlation between multinucleated cells (MNCs) and cancer chemo-resistance in variety of cancers, our understanding of how multinucleated cells modulate the tumor micro-environment is limited. We captured multinucleated cells from triple-negative chemo-resistant breast cancers cells in a time frame, where they do not proliferate but rather significantly regulate their micro-environment. We show that oxidatively stressed MNCs induce chemo-resistance in vitro and in vivo by secreting VEGF and MIF. These factors act through the RAS/MAPK pathway to induce chemo-resistance by upregulating anti-apoptotic proteins. In MNCs, elevated reactive oxygen species (ROS) stabilizes HIF-1α contributing to increase production of VEGF and MIF. Together the data indicate, that the ROS-HIF-1α signaling axis is very crucial in regulation of chemo-resistance by MNCs. Targeting ROS-HIF-1α in future may help to abrogate drug resistance in breast cancer.
Asunto(s)
Resistencia a Antineoplásicos/fisiología , Especies Reactivas de Oxígeno/metabolismo , Neoplasias de la Mama Triple Negativas/metabolismo , Mama/metabolismo , Línea Celular Tumoral , Femenino , Humanos , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Factores Inhibidores de la Migración de Macrófagos/metabolismo , Transducción de Señal/fisiología , Microambiente Tumoral/fisiología , Factor A de Crecimiento Endotelial Vascular/metabolismoRESUMEN
In this study, we examined potential adverse health effect of particulate matter (PM) collected from industrial areas of Rourkela, Odisha, India. Results indicate that PM in these areas contains benzo[a]pyrene in addition to other unidentified molecules. Ames test revealed the above PM to be highly mutagenic. Further studies of PM in HaCaT cells suggest its DNA damaging potential which may lead to apoptosis. Generation of reactive oxygen and nitrogen species following PM exposure may be an early event in the PM induced apoptosis. In addition, the activity of cytochrome P450 (CYP450), the key xenobiotic metabolism enzyme, was found to be increased following PM exposure indicating its role in PM induced toxicity. To confirm this, we used genetic and pharmacological inhibitors of CYP450 like CYP1B1 siRNA and Clotrimazole. Interestingly, we found that the use of these inhibitors significantly suppressed the PM induced apoptosis in HaCaT cells, which confirm the crucial role of CYP1B1 in the toxic manifestation of PM. For further analysis, blood samples were collected from the volunteer donor and analyzed for immunophenotypes and comet assay to survey any change in immune cells and DNA damage in blood cells respectively. The study was performed with 55 blood samples including 32 from industrial areas and 23 people from non-industrial zone of Rourkela city. Samples had a mean±SD age of 35±6.2years (35 men and 20 women). Our investigation did not observe any significant alteration in lymphocytes (P=0.671), B cell (P=0.104), cytotoxic T cell (P=0.512), helper T cell (P=0.396), NK cell (P=0.675) and monocytes (P=0.170) of blood cells from these two groups. Taken together; this study first time reports the possible health hazards of PM from industrial areas of Odisha, India.
Asunto(s)
Exposición a Riesgos Ambientales/análisis , Material Particulado/análisis , Material Particulado/toxicidad , Contaminantes Atmosféricos/análisis , Contaminantes Atmosféricos/farmacocinética , Contaminantes Atmosféricos/toxicidad , Animales , Apoptosis/genética , Línea Celular , Ciudades , Ensayo Cometa , Citocromo P-450 CYP1B1/genética , Citocromo P-450 CYP1B1/metabolismo , Daño del ADN/efectos de los fármacos , Humanos , Inactivación Metabólica , India , Queratinocitos/efectos de los fármacos , Queratinocitos/patología , Espectroscopía de Resonancia Magnética , Ratones , Pruebas de Mutagenicidad/métodos , Material Particulado/farmacocinética , Especies Reactivas de Oxígeno/metabolismo , Espectrometría de FluorescenciaRESUMEN
Melanoma is one of the most aggressive forms of cancer, usually resistant to standard chemotherapeutics. Despite a huge number of clinical trials, any success to find a chemotherapeutic agent that can effectively destroy melanoma is yet to be achieved. Para-phenylenediamine (p-PD) in the hair dyes is reported to purely serve as an external dyeing agent. Very little is known about whether p-PD has any effect on the melanin producing cells. We have demonstrated p-PD mediated apoptotic death of both human and mouse melanoma cells in vitro. Mouse melanoma tumour growth was also arrested by the apoptotic activity of intraperitoneal administration of p-PD with almost no side effects. This apoptosis is shown to occur primarily via loss of mitochondrial membrane potential (MMP), generation of reactive oxygen species (ROS), and caspase 8 activation. p-PD mediated apoptosis was also confirmed by the increase in sub-G0/G1 cell number. Thus, our experimental observation suggests that p-PD can be a potential less expensive candidate to be developed as a chemotherapeutic agent for melanoma.
RESUMEN
The objective of the present study was to fabricate and monitor real-time, impact of a stable conjugated linolenic acid, α-eleostearic acid (ESA) rich nanoemulsion (NE) formulation (d < 200 nm) vis-à-vis ESA conventional emulsion (CE) system in ex vivo systems against both endogenous and exogenous reactive oxygen species (ROS). Accordingly, stable nanoemulsion formulation of ESA was engineered with the aid of bitter melon seed oil and non-toxic excipients. Morphology and particle size of the emulsion formulations were studied to validate stability. The real-time rapid uptake of the ESA NE and its increased prophylactic efficacy against induced endogenous and exogenous ROS in terms of cell viability and membrane integrity was evaluated flow-cytometrically and with fluorescence microscopic analysis of different primary cells. It was found that the fabricated non-toxic ESA NE had stable parameters (hydrodynamic mean diameter, particle size distribution and zeta potential) for over 12 weeks. Further, ESA NE at a concentration of â¼ 70 µM exhibited maximum efficacy in protecting cells from oxidative damage against both endogenous and exogenous ROS in lymphocytes and hepatocytes as compared to its corresponding presence in the CE formulation. This study provides a real-time empirical evidence on the influence of nano formulation in enhancing bioavailability and antioxidative properties of ESA.
Asunto(s)
Leucocitos Mononucleares/química , Nanoestructuras/química , Ácido alfa-Linolénico/química , Muerte Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Emulsiones/química , Emulsiones/farmacología , Humanos , Leucocitos Mononucleares/citología , Leucocitos Mononucleares/metabolismo , Sustancias Macromoleculares/química , Sustancias Macromoleculares/farmacología , Tamaño de la Partícula , Especies Reactivas de Oxígeno/metabolismo , Relación Estructura-Actividad , Propiedades de Superficie , Factores de Tiempo , Ácido alfa-Linolénico/farmacologíaRESUMEN
Platelet signatures indicating differential dysfunction, hyperactivation, aggregation or adhesion are capable of expressing their characters during the journey of a disease process, and can be utilized as cost effective biomarkers with immense clinical value. Type 2 diabetes mellitus (T2DM) is a major lifestyle disease of contemporary world with progression to diabetes associated cardiovascular diseases (DM-CVD). We identified a few potential biomarkers in platelets of T2DM to analyze the thrombotic risk in diabetes subjects by utilizing flow cytometric quantification with different flurochrome conjugated monoclonal antibodies. Our study describes interesting correlations (p<0.0001) for different clinical parameters of concurrent threat for vessel occlusion and the status of indices like reactive oxygen species, von Willebrand factor and mitochondrial membrane potential using western blotting and fluorescence techniques. Our study involved 32 T2DM, and 31 T2DM-CVD subjects compared to 29 healthy controls without any history of T2DM or CVD. An altered expression of platelet surface markers P-selectin (CD62p) and GpIIb/IIIa (CD 41/61, PAC1) along with changes in the platelet size due to agonist induced activation contributed to the enhanced thrombotic potential in the patients. This work elucidates the prospect of platelet biomarkers as diagnostic tool to predict cardiovascular risk in DM subjects.
Asunto(s)
Plaquetas/patología , Enfermedades Cardiovasculares/complicaciones , Enfermedades Cardiovasculares/diagnóstico , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/diagnóstico , Biomarcadores/análisis , Femenino , Citometría de Flujo , Humanos , Masculino , Potencial de la Membrana Mitocondrial , Persona de Mediana Edad , Selectina-P/análisis , Complejo GPIIb-IIIa de Glicoproteína Plaquetaria/análisis , Especies Reactivas de Oxígeno/análisis , Factores de Riesgo , Factor de von Willebrand/análisisRESUMEN
A unique event in bacterial epidemiology was the emergence of the El Tor biotype of Vibrio cholerae O1 and the subsequent rapid displacement of the existing classical biotype as the predominant cause of epidemic cholera. We demonstrate that when the El Tor and classical biotypes were cocultured in standard laboratory medium a precipitous decline in colony forming units (CFU) of the classical biotype occurred in a contact dependent manner. Several lines of evidence including DNA release, microscopy and flow cytometric analysis indicated that the drastic reduction in CFU of the classical biotype in cocultures was not accompanied by lysis, although when the classical biotype was grown individually in monocultures, lysis of the cells occurred concomitant with decrease in CFU starting from late stationary phase. Furthermore, uptake of a membrane potential sensitive dye and protection of genomic DNA from extracellular DNase strongly suggested that the classical biotype cells in cocultures retained viability in spite of loss of culturability. These results suggest that coculturing the classical biotype with the El Tor biotype protects the former from lysis allowing the cells to remain viable in spite of the loss of culturability. The stationary phase sigma factor RpoS may have a role in the loss of culturability of the classical biotype in cocultures. Although competitive exclusion of closely related strains has been reported for several bacterial species, conversion of the target bacterial population to the viable non-culturable state has not been demonstrated previously and may have important implications in the evolution of bacterial strains.
Asunto(s)
Técnicas de Tipificación Bacteriana/métodos , Viabilidad Microbiana , Vibrio cholerae/clasificación , Vibrio cholerae/crecimiento & desarrollo , Bacteriólisis , Técnicas de Cocultivo , Recuento de Colonia Microbiana , Desoxirribonucleasas/metabolismo , Citometría de Flujo , Concentración de Iones de Hidrógeno , Ensayos de Protección de Nucleasas , Vibrio cholerae/citologíaRESUMEN
Mushroom-derived polysaccharides like ß-glucan are being investigated for therapeutic properties for a long time, but their mode of action of immunomodulatory properties is not well established. In the present study, a heteroglucan from Astraeus hygrometricus designated as AE2 is investigated for its macrophage stimulatory properties using RAW 264.7 cell line. An augmentation of nitric oxide production is observed in the presence of AE2 in a dose-dependent manner due to up-regulation of iNOS (inducible NO synthase) expression; hence NF κB (nuclear factor κB) pathway is investigated. RAW 264.7 cells endured phosphorylation of Ikk (IκB kinase) and subsequently NF κB is translocated to the nucleus. Further, the PKC (protein kinase C) level of the cells enhanced significantly. We also found that AE2 could induce the phosphorylation of p38 MAPK (mitogen-activated protein kinase), ERK1/2 (extracellular-signal-regulated kinase 1/2), MEK (MAPK/ERK kinase) and JNK (c-Jun N-terminal kinase), whereas it failed to induce phosphorylation of JAK2 (Janus kinase 2) and STAT1. These results indicated that the macrophage activation by AE2 might be exerted, at least in part, via MAPKs (mitogen-activated protein kinases) pathway of signal transduction.
Asunto(s)
Basidiomycota/metabolismo , Glucanos/farmacología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Animales , Línea Celular Tumoral , Proteínas I-kappa B/genética , Proteínas I-kappa B/metabolismo , Proteínas Quinasas JNK Activadas por Mitógenos/genética , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Janus Quinasa 2/genética , Janus Quinasa 2/metabolismo , Ratones , Proteína Quinasa 1 Activada por Mitógenos/genética , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/genética , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , FN-kappa B/genética , FN-kappa B/metabolismo , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo II/genética , Óxido Nítrico Sintasa de Tipo II/metabolismo , Fosforilación , Factor de Transcripción STAT1/genética , Factor de Transcripción STAT1/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/genética , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismoRESUMEN
Mushrooms have been used as food and for therapeutic purpose for decades, and various compounds derived from these have potential biological activities. Application of such agents of natural origin is vital with relevance to an increase in diseases involving immune dysfunction, cancer, and autoimmune conditions in recent years. These compounds belong mainly to polysaccharides, especially beta-D-glucan, glycopeptide/protein complexes, proteoglycans, proteins, and triterpenoids. Among these compounds, polysaccharides and their peptide/protein derivates have extremely important roles in immunomodulating activities. The present study aims to explore the immunomodulatory properties of polysaccharide isolated from the mushroom Astraeus hygrometricus. The polysaccharide isolated by hot alkaline extraction and chromatography was designated as AE2 and studied for its immunostimulatory potential in vivo in a murine model. Macrophages from treated mice showed higher production of nitric oxide and interleukin-1 and also exhibited an increased phagocytic potential. It also enhanced natural killer cell activation and proliferation of splenocytes with an increase in the T-helper (Th) 1 cytokine level of splenocyte culture supernatant. The cytokine level in serum also indicated a Th1 skew. The observed activities were associated with no general toxicity to the organism. The findings will be helpful in considering A. hygrometricus as a potential source of an immunomodulator and in designing further studies to understand its mode of action on immune system.
Asunto(s)
Basidiomycota/inmunología , Factores Inmunológicos/inmunología , Polisacáridos/inmunología , Animales , Basidiomycota/química , Células Cultivadas , Citocinas/inmunología , Factores Inmunológicos/aislamiento & purificación , Factores Inmunológicos/farmacología , Células Asesinas Naturales/efectos de los fármacos , Células Asesinas Naturales/inmunología , Activación de Linfocitos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Masculino , Ratones , Polisacáridos/aislamiento & purificación , Polisacáridos/farmacologíaRESUMEN
Most tumours arise from a single normal cell through a sequential evolutionary process of mutation and selection. Tumours are initiated by escaping non-immune surveillance, which includes defective DNA repair, epigenetic gene alternation, resistance to apoptosis and loss of intercellular contact inhibition. Tumour cells harbour mutations in a number of critical genes that provide selective advantages at various stages during the evolution of the tumour. The tumour cells that circumvent the tumour suppressor mechanisms of the non-immune surveillance process are edited by the immune system, resulting in the selection of a resistant tumour variant. The selection of the tumour cell is further shaped by its interactions with cells and other factors in its microenvironment. Tumour evolution is thought to adhere to Darwinian principles by escaping both non-immune (intrinsic) and immune (extrinsic) responses against self-altered tumour cells. At end-stage, tumours have escaped both non-immune and immune surveillance with increased threshold of apoptosis. Combination therapy has been proposed, by exploring the non-immune and immune suppressive nature of the tumour, and has been found to have a therapeutic efficiency on tumour regression as compared with monotherapies. The combination of immunotherapy and other different modalities, especially vaccines, with conventional anticancer therapies with optimized dosage and scheduling can offer synergistic antitumour effects. Here, we focus on the mechanism of tumour evolution and its implication in combination therapy.
Asunto(s)
Inmunoterapia/métodos , Neoplasias/inmunología , Neoplasias/terapia , Escape del Tumor/inmunología , Apoptosis/inmunología , Vacunas contra el Cáncer/uso terapéutico , Terapia Combinada , Epigénesis Genética , Humanos , Sistema Inmunológico/inmunología , Vigilancia Inmunológica/inmunología , Linfocitos/inmunología , Neoplasias/genética , Neoplasias/patologíaRESUMEN
In our previous study, Abrus abrin derived peptide fraction (ABP) with molecular weight in range of 600-1500Da was shown to have potent antitumor activity in Dalton's lymphoma (DL) tumor bearing mice. The purpose of this study was to elucidate the mechanism of mitochondrial apoptosis induced by the peptide fraction. ABP was found to have selective antiproliferative activity (10ng-100ng/ml) on several tumor cell lines in vitro without having any cytotoxic effect on normal cell lines with a dose of 1000ng/ml. Analysis of the growth inhibitory mechanism in HeLa cells revealed DNA fragmentation with appearance of the sub G(0)/G(1) peak indicative of apoptosis. Further investigation results showed that the apoptotic machinery of HeLa induced by ABP was associated with the release of reactive oxygen species, a drop in mitochondrial transmembrane potential, upregulation of Bax, downregulation of Bcl-2, and activation of caspase-3. The peptide fraction was found to target mitochondria of HeLa cells as observed by confocal microscopy. This peptide fraction offers a source of mitochondria penetrating peptides which might have therapeutic induction of apoptosis in cancer cells.
Asunto(s)
Abrina/química , Abrus/química , Antineoplásicos Fitogénicos/farmacología , Apoptosis , Mitocondrias/metabolismo , Péptidos/farmacología , Caspasa 3/metabolismo , Línea Celular Tumoral , Células HeLa , Humanos , Interfase , Potenciales de la Membrana , Mitocondrias/efectos de los fármacos , Péptidos/química , Proteína X Asociada a bcl-2/metabolismoRESUMEN
In vitro immunostimulatory effect of Abrus lectins derived peptide fractions (AGP and ABP) was investigated in DL bearing mice. Both AGP and ABP were found to activate splenocytes and induced production of cytokines like IL-2, IFN-gamma and TNF-alpha indicating a Th1 type of immune response. Analysis of in vitro treated splenocytes by flow cytometry revealed an increase in percentage of T and B cell with high expression of activation markers (CD25(+) and CD71(+)). At the same time, expression of co-stimulatory markers was significantly high compared to tumor control. The tumor associated macrophages were able to stimulate NO production, IL-1 secretion, increased phagocytosis and decreased expression of mannose receptor. It was also observed that NK cell was activated by AGP and ABP. These results suggest that both AGP and ABP act as immunostimulants in vitro in DL bearing mice.
Asunto(s)
Abrina/metabolismo , Abrus/química , Adyuvantes Inmunológicos/uso terapéutico , Aglutininas/metabolismo , Antineoplásicos Fitogénicos/uso terapéutico , Linfoma/tratamiento farmacológico , Péptidos/uso terapéutico , Adyuvantes Inmunológicos/farmacología , Animales , Antígenos CD/metabolismo , Antineoplásicos Fitogénicos/farmacología , Linfocitos B/efectos de los fármacos , Línea Celular Tumoral , Citocinas/biosíntesis , Citocinas/metabolismo , Subunidad alfa del Receptor de Interleucina-2/metabolismo , Células Asesinas Naturales/efectos de los fármacos , Lectinas Tipo C/antagonistas & inhibidores , Macrófagos/efectos de los fármacos , Receptor de Manosa , Lectinas de Unión a Manosa/antagonistas & inhibidores , Ratones , Óxido Nítrico/biosíntesis , Péptidos/metabolismo , Péptidos/farmacología , Fagocitosis/efectos de los fármacos , Fitoterapia , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Plantas Medicinales/química , Receptores de Superficie Celular/antagonistas & inhibidores , Receptores de Transferrina/metabolismo , Semillas , Bazo/citología , Bazo/efectos de los fármacos , Linfocitos T/efectos de los fármacosRESUMEN
In our previous studies, Abrus agglutinin showed non-specific immunostimulatory activity both native (NA) and heat-denatured (HDA) condition in mouse model. The present study was investigated to decipher the specific immune response towards B and T cell by NA and HDA. It was observed that the proliferation index for NA and HDA of stimulated B cells are 1.35 and 1.41 respectively and on the other hand, T cell proliferation index for NA and HDA are 1.67 and 1.54 respectively. At the same time, expression of surface and activation marker for B and T cells was significantly different compared to control as quantified by flow cytometry. But the expression of co-stimulatory markers (CD 80 and CD 86) was not significantly different and NA and HDA in immunized splenocytes with Dalton's lymphoma antigen induced antibodies titer 4.37 and 4.2 times more than control. This study indicates Abrus agglutinin (NA and HDA) acts as a B cell and T cell stimulator.
Asunto(s)
Abrus/inmunología , Linfocitos B/metabolismo , Activación de Linfocitos/efectos de los fármacos , Lectinas de Plantas/farmacología , Linfocitos T/metabolismo , Animales , Linfocitos B/citología , Linfocitos B/efectos de los fármacos , Linfocitos B/inmunología , Antígeno B7-1/genética , Antígeno B7-1/inmunología , Antígeno B7-1/metabolismo , Proliferación Celular/efectos de los fármacos , Ciclosporina/farmacología , Citometría de Flujo , Calor , Separación Inmunomagnética , Activación de Linfocitos/inmunología , Ratones , Lectinas de Plantas/química , Conformación Proteica , Desnaturalización Proteica , Semillas , Bazo/citología , Linfocitos T/citología , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunologíaRESUMEN
Peptides derived from larger molecules that are important modulators in cancer regression are becoming leads for development of therapeutic drugs. It has been reported that Abrus abrin, isolated from the seeds of Abrus precatorius, showed in vitro and in vivo antitumor properties by the induction of apoptosis. The present study was designed to evaluate the in vivo therapeutic effectiveness of abrin-derived peptide (ABP) fraction in Dalton's lymphoma (DL) mice model. The lethal dose (LD(50)) of ABP was found to be 2.25 mg/kg body weight and further the acute toxicity was determined with sublethal doses in normal mice. The acute toxicity like body weight, peripheral blood cell count, lympho-hematological and biochemical parameters remained unaffected till 200 microg/kg body weight of ABP. The sublethal doses of ABP showed very significant growth inhibitory properties in vivo DL mice model. There were 24%, 70.8% and 89.7% reductions in DL cell survival in 25, 50 and 100 microg/kg body weight of ABP, respectively. Analysis of the growth inhibitory mechanism in DL cells revealed nuclear fragmentation, and condensation with the appearance of the sub-G(0)/G(1) peak is indicative of apoptosis. Further, the Western blotting showed that apoptosis was mediated by the reduction in the ratio of Bcl-2 and Bax protein expression, and activation of caspase-3 through the release of cytochrome c in DL cells. Kaplan-Meier survival analysis showed an effective antitumor response (104.6 increase in life span (ILS) %) with a dose of 100 microg/kg body weight.
Asunto(s)
Abrina/uso terapéutico , Abrus , Antineoplásicos Fitogénicos/uso terapéutico , Apoptosis , Linfoma/tratamiento farmacológico , Péptidos/uso terapéutico , Proteínas de Plantas/uso terapéutico , Abrina/toxicidad , Animales , Antineoplásicos Fitogénicos/toxicidad , Apoptosis/efectos de los fármacos , Ascitis/tratamiento farmacológico , Recuento de Células Sanguíneas , Glucemia/metabolismo , Peso Corporal/efectos de los fármacos , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Femenino , Hematología , Dosificación Letal Mediana , Ratones , Péptidos/toxicidad , Fitoterapia , Proteínas de Plantas/toxicidad , Semillas , Bazo/efectos de los fármacos , Sobrevida , Timo/efectos de los fármacosRESUMEN
Abrus agglutinin peptide fractions obtained from 10 kD molecular weight cut off membrane permeate (10 kMP), was shown to have selective antiproliferative activity on several tumor cell lines with induction of apoptosis through mitochondrial pathway. The present study was designed to evaluate acute general toxicity and in vivo therapeutic effectiveness of 10 kMPP in Dalton's lymphoma (DL) mice model. The acute toxicity like body weight, peripheral blood cell count, lympho-hematological and biochemical parameters remained unaffected with 1mg/kg body weight and lower of 10 kMPP. The in vivo antitumor study indicated that there were 27%, 58.5% and 84.5% reduction in DL cell survival in 100, 200 and 500 microg/kg body weight of 10 kMPP, respectively. Analysis of the growth inhibitory mechanism in DL cells revealed nuclear fragmentation and condensation with appearance of the sub G0/G1 peak is indicative of apoptosis. Further, the Western blotting showed apoptosis was mediated by reduction in ratio of Bcl-2 and Bax protein expression, and activation of caspase-3 through release of cytochrome-c in DL cells. Kaplan-Meier survival analysis showed an effective antitumor response (53 ILS%) with dose of 500 microg/kg body weight. Our result showed that the novel peptides present in Abrus agglutinin possess potent antitumor properties which need to be further explored.
Asunto(s)
Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Linfoma/patología , Péptidos/farmacología , Lectinas de Plantas/farmacología , Animales , Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Ensayos de Selección de Medicamentos Antitumorales , Femenino , Citometría de Flujo , Ratones , Peso Molecular , Análisis de SupervivenciaRESUMEN
In our previous study, Abrus agglutinin showed antitumor activity both native and heat-denatured condition in mouse model. The purpose of this study is to explore the presence of anticancer peptide in agglutinin, and to elucidate the mechanism of its activity in vitro. A tryptic digested Abrus agglutinin peptide fractions obtained from 10-kDa molecular weight cut off membrane permeate (10 kMPP), was found to have selective antiproliferative activity (1-10 microg/ml) on several tumor cell lines in vitro without having any cytotoxic effect on normal cell lines with dose of 100 microg/ml. Analysis of the growth inhibitory mechanism in HeLa cells revealed nuclear fragmentation and condensation with appearance of the sub-G 0/G1 peak indicative of apoptosis. Furthermore, the peptide fraction induced the apoptosis signal via generation of reactive oxygen species and decrease in the Bcl-2/Bax ratio thereby inducing mitochondrial permeability transition with consequent activation of caspase-3, finally leads to DNA fragmentation, and the hallmark of apoptosis. LC-MS/MS analysis reflected the molecular masses of peptides in 10 kMPP were in the range of 500 Da to 3000 Da. The significant antitumor activity of 10 kMPP deserves further laboratory and in vivo experimentation.
Asunto(s)
Abrus/química , Aglutininas/farmacología , Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Mitocondrias/fisiología , Péptidos/farmacología , Aglutininas/química , Antineoplásicos Fitogénicos/química , Caspasa 3/metabolismo , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Citocromos c/metabolismo , Fragmentación del ADN/efectos de los fármacos , Femenino , Fluoresceína-5-Isotiocianato , Colorantes Fluorescentes , Células HeLa , Humanos , Indicadores y Reactivos , Potenciales de la Membrana/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Peso Molecular , Péptidos/química , Especies Reactivas de Oxígeno , Sales de Tetrazolio , Tiazoles , Ensayo de Tumor de Célula MadreRESUMEN
Fruit bodies and mycelia of various higher Basidiomycetes were studied in search of biological effector molecules. In this study, we evaluated the antiproliferative and immunomodulatory properties of a protein fraction designated as Cibacron blue affinity eluted protein (CBAEP) isolated from five different species of edible mushrooms (Termitomyces clypeatus, Pleurotus florida, Calocybe indica, Astraeus hygrometricus, and Volvariella volvacea). This protein fraction (10-100µg/ml) mediated antiproliferative activity on several tumor cell lines through the induction of apoptosis. Also the isolated protein fraction from all five mushrooms had a stimulatory effect on splenocytes, thymocytes and bone marrow cells. Further it enhanced mouse natural killer (NK) cell cytotoxicity and stimulated macrophages to produce nitric oxide (NO). The highest immunostimulatory activity was determined in the CBAEP from T. clypeatus and the highest antiproliferative activity from C. indica.
RESUMEN
In this study a major lectin called Concanavalin A (ConA) has been micropatterned on a glass substrate by microcontact printing and the patterns have been characterized with fluorescent and atomic force microscope for their uniformity. Interaction of the patterns with mammalian cells has been investigated by culturing L929 mouse fibroblast cells on the ConA printed glass surface. Cell culture results obtained from the microcontact printed patterns have also been compared and benchmarked with another patterning technique named micromolding in capillaries (MIMIC). It has been revealed that in spite of molecular level heterogeneity and agglomeration of protein molecules in microcontact printed form, they can still interact with cell surface glycoproteins, impede the mobility of membrane receptor which results in altered morphology of the fibroblast cells.